Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
TEST:
OverC™
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Burning Rock Biotech
Type:
CE Marked
Related tests:
‹
OncoCompass™ Target (1)
LungCure™ CDx
OncoScreen Plus®
OncoScreen™ Focus CDx Tissue Kit
OncoScreen™ IO
OncoCompass™ Target (1)
LungCure™ CDx
OncoScreen Plus®
OncoScreen™ Focus CDx Tissue Kit
OncoScreen™ IO
›
Details
Evidence
News
Search handles
Search handles
Filter by
Latest
almost3years
The FDA has granted a breakthrough device designation to the OverC Multi-Cancer Detection Blood Test (MCDBT) for the early detection of cancers including esophageal, liver, lung, ovarian, and pancreatic in 50 - 75 y/o with average risk https://t.co/lP4vcWOLZH via @onclive ()
almost 3 years ago
FDA event
|
OverC™
Share
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.